- Home
- MOLN vs NKSH Comparison
MOLN vs NKSH Comparison
Compare MOLN & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- NKSH
- Stock Information
- Founded
- MOLN 2004
- NKSH 1891
- Country
- MOLN Switzerland
- NKSH United States
- Employees
- MOLN N/A
- NKSH N/A
- Industry
- MOLN
- NKSH Major Banks
- Sector
- MOLN
- NKSH Finance
- Exchange
- MOLN Nasdaq
- NKSH Nasdaq
- Market Cap
- MOLN 195.4M
- NKSH 180.8M
- IPO Year
- MOLN 2021
- NKSH N/A
- Fundamental
- Price
- MOLN $5.40
- NKSH $27.59
- Analyst Decision
- MOLN
- NKSH Strong Buy
- Analyst Count
- MOLN 0
- NKSH 1
- Target Price
- MOLN N/A
- NKSH $38.00
- AVG Volume (30 Days)
- MOLN 8.3K
- NKSH 13.5K
- Earning Date
- MOLN 08-26-2024
- NKSH 10-24-2024
- Dividend Yield
- MOLN N/A
- NKSH 5.59%
- EPS Growth
- MOLN N/A
- NKSH N/A
- EPS
- MOLN N/A
- NKSH 1.44
- Revenue
- MOLN $7,105,397.00
- NKSH $43,450,000.00
- Revenue This Year
- MOLN N/A
- NKSH N/A
- Revenue Next Year
- MOLN $29.41
- NKSH $19.72
- P/E Ratio
- MOLN N/A
- NKSH $18.68
- Revenue Growth
- MOLN N/A
- NKSH N/A
- 52 Week Low
- MOLN $3.32
- NKSH $26.00
- 52 Week High
- MOLN $12.70
- NKSH $35.00
- Technical
- Relative Strength Index (RSI)
- MOLN 51.92
- NKSH 39.62
- Support Level
- MOLN $4.98
- NKSH $26.00
- Resistance Level
- MOLN $5.50
- NKSH $28.60
- Average True Range (ATR)
- MOLN 0.20
- NKSH 0.90
- MACD
- MOLN 0.03
- NKSH -0.16
- Stochastic Oscillator
- MOLN 86.04
- NKSH 38.78
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.